Ramsha Samra
Foot & Ankle Surgery · Wyandotte, MINPI 1467077644
Payments from drug & device makers
Across 50 payments — averaging $127.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pinnacle, Inc$2K
- Orthofix Medical, Inc.$2K
- Paragon 28, Inc.$1K
- Medical Device Business Services, Inc.$696
- Smith+Nephew$216
- Medtronic$172
- plus $280 from 12 others
What the payments were for
- Travel & lodging$2,69742%
- Food & beverage$1,29620%
- Education$2,40038%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pinnacle, Inc | 5 | $2,428 |
| Orthofix Medical, Inc. | 13 | $1,539 |
| Paragon 28, Inc. | 6 | $1,061 |
| Medical Device Business Services, Inc. | 6 | $696 |
| Smith+Nephew | 5 | $216 |
| Medtronic | 2 | $172 |
| Johnson & Johnson(2 entities) | 2 | $45 |
| Acumed LLC | 1 | $35 |
| Aroa Biosurgery Incorporated | 1 | $35 |
| AbbVie | 1 | $26 |
| Nevro Corp. | 1 | $23 |
| Baxter Healthcare | 1 | $20 |
| Arteriocyte Medical Systems, Inc. | 1 | $19 |
| Mimedx Group, Inc. | 1 | $17 |
| Bioventus LLC | 1 | $17 |
| Reprise Biomedical, Inc. | 1 | $15 |
| Vertex | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TrueLok$2,646
- Portfolio$803
- INTELLIS ADAPTIVESTIM$151
- Precision MIS Bunion$133
- Stravix$121
How this compares
$6,393 in reported general payments places this provider in the 65th percentile of 384 foot & ankle surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 31 | $874 |
| Diclofenac Sodium | 30 | $682 |
| Ketoconazole | 33 | $681 |
| Ammonium Lactate | 27 | $269 |
| Mupirocin | 26 | $140 |
| Doxycycline Hyclate | 15 | $116 |
| Gabapentin | 11 | $60 |
| Meloxicam | 19 | $35 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Wyandotte
- Zuhair IrfanWyandotte$29K
- Nsima UsenWyandotte$27K
- John AndersonGrand Rapids$1.3M
- Brian LoderClinton Township$893K
- Karl DunnClinton Twp$434K
- John MaskillGrand Rapids$424K
- Anthony LalamaMacomb$421K
- Christopher ZingasSaint Clair Shores$227K
- Michael SwordsLansing$202K
- Gregory SheremetaTroy$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.